ENTITY
Macrogen Inc

Macrogen Inc (038290 KS)

8
Analysis
Health Care • South Korea
Macrogen Inc. provides DNA sequencing and genome research services. The Company also raises and sells transgenic and knockout mice to biotechnology institutes and pharmaceutical companies. Macrogen develops DNA chips, which are used to improve the diagnosis and treatment of disease as well.
more
•20 Feb 2017 06:10

ASTA IPO Part 2 - Growth Potential & Appropriate Valuation Level

* In Part 2 (as below), I summarized the company's growth potential and appropriate valuation level.Who is ASTA again? The company is a biomass...

Logo
611 Views
Share
•04 Dec 2016 02:39

ASTA IPO Part 1 - Schedule, Financials & Valuation

ASTA (Applied Surface Technology) (established in 2006) submitted the IPO report. ASTA is a technology-based company that develops and manufactures...

Logo
347 Views
Share
•07 Jul 2016 00:13

SillaJen's December IPO: Valuation, Growth Expectation and IPO Timing

SillaJen Biotherapeutics (established in 2006) is indeed a rare breed in Korean pharmaceutical world. It is not a generic drug maker. It is not a...

Logo
3.6k Views
Share
x